Eleonora Mungo

Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo

Stephan Göttig, Denia Frank, Eleonora Mungo et al. · Journal of Antimicrobial Chemotherapy · 2019 · 95 citations

Life Sciences, Infectious Diseases, Microbiology +17

Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean et al. · Molecular Cancer Therapeutics · 2016 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17

Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

Iris C. Salaroglio, Elena Gazzano, Ahmad Abdullrahman et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells

Loredana Bergandi, Eleonora Mungo, Rosa Morone et al. · Frontiers in Pharmacology · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Distinct molecular mechanisms contribute to the reduction of melanoma growth and tumor pain after systemic and local depletion of <scp>alpha‐Synuclein</scp> in mice

Ellen Niederberger, Moritz Möller, Eleonora Mungo et al. · The FASEB Journal · 2023 · 14 citations · Full text

Life Sciences, Neuroscience, Oncology +14